輸入代號或公司名稱後按 Enter
4164

承業醫

+0.30 (+1.19%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
25.50271成交張數21.79本益比0.66股價淨值比4.35%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.3239.1%1.170.635.3%0.84%3.11%
2026Q10.13160.0%1.080.262.3%0.35%2.85%
2025Q40.3633.3%1.000.705.8%0.92%2.67%
2025Q30.36-35.7%0.910.676.1%0.92%2.33%
2025Q20.2335.3%1.110.413.8%0.58%2.83%
2025Q10.05400.0%1.050.080.8%0.13%2.68%
2024Q40.27-77.9%1.010.454.4%0.72%2.64%
2024Q30.56115.4%1.960.939.6%1.49%5.17%
2024Q20.17-70.7%1.660.282.9%0.46%4.45%
2024Q10.01-98.0%2.070.020.3%0.04%5.62%
2023Q41.22134.6%2.552.0113.8%3.16%6.65%
2023Q30.26-58.7%1.850.435.9%0.70%4.90%
2023Q20.58-15.9%2.220.9610.8%1.57%5.95%
2023Q10.4932.4%2.330.799.9%1.30%6.35%
2022Q40.52-39.5%2.210.849.8%1.37%5.83%
2022Q30.6346.5%2.551.0112.4%1.69%6.91%
2022Q20.6946.8%2.351.1116.1%1.89%6.25%
2022Q10.37-44.8%2.130.609.9%1.01%5.72%
2021Q40.86196.6%2.431.3615.5%2.29%6.40%
2021Q30.43-60.6%1.860.6714.0%1.14%5.17%
2021Q20.47-26.6%2.520.7416.6%1.23%6.93%
2021Q10.6731.4%2.691.0516.4%1.78%7.17%
2020Q40.29-47.3%2.530.489.0%0.84%6.66%
2020Q31.09-0.9%2.791.5618.8%2.95%7.42%
2020Q20.64-14.7%2.800.9114.3%1.77%7.92%
2020Q10.5118.6%2.910.7112.8%1.37%7.93%
2019Q40.55-9.8%2.830.7812.8%1.52%7.80%
2019Q31.1054.9%2.891.5416.3%3.08%8.04%
2019Q20.75-14.8%2.501.0413.6%2.09%7.11%
2019Q10.43258.3%2.630.609.5%1.19%7.36%
2018Q40.612.320.8412.7%1.71%6.54%
2018Q30.71317.6%0.260.9913.5%2.03%0.76%
2018Q20.88528.6%-0.281.2317.3%2.51%-0.81%
2018Q10.12-76.9%-1.020.174.3%0.35%-2.87%
2017Q4-1.45-262.9%-0.62-2.02-32.7%-4.15%-1.75%
2017Q30.1754.5%1.720.234.9%0.47%4.98%
2017Q20.1427.3%1.660.204.4%0.41%4.79%
2017Q10.521633.3%1.630.7212.6%1.45%4.48%
2016Q40.891.141.2515.4%2.55%
2016Q30.110.153.8%0.31%